Skip to main content
. 2019 Jan 10;12:6. doi: 10.1186/s13045-018-0696-z

Fig. 2.

Fig. 2

Outcomes of AITL patients based on the receipt of prior auto-HCT vs no prior auto-HCT. a Cumulative incidence of non-relapse mortality. b Cumulative incidence of lymphoma progression/relapse. c Progression-free survival. d Overall survival